PROSPECTIVE RANDOMIZED COMPARISON OF HUMAN CHORIONIC-GONADOTROPIN VERSUS INTRAMUSCULAR PROGESTERONE FOR LUTEAL-PHASE SUPPORT IN ASSISTED REPRODUCTION

被引：68
作者：
ARAUJO, E [1 ]
BERNARDINI, L [1 ]
FREDERICK, JL [1 ]
ASCH, RH [1 ]
BALMACEDA, JP [1 ]
机构：
[1] UNIV CALIF IRVINE,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,POB 14091,ORANGE,CA 92613
来源：
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS | 1994年 / 11卷 / 02期
关键词：
LUTEAL-PHASE SUPPLEMENTATION THERAPY; OVARIAN HYPERSTIMULATION SYNDROME; IMPLANTATION RATES;
D O I：
10.1007/BF02215991
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Objective: The purpose of the study was to determine the impact of two forms of luteal-phase supplementation, human chorionic gonadotropin (hCG) and progesterone (P), during gonadotropin releasing hormone agonist (GnRha)/controlled ovarian hyperstimulation (COH) cycles. Design and Patients: The study was a prospective, randomized evaluation of 77 patients. Group 1 patients (n = 38) received 2000 IU of hCG, injected subcutaneously, on days 3, 6, 9, and 12 after transvaginal aspiration of the oocytes (TVA = day 0). Group 2 patients (n = 39) received 50-mg daily injections of intramuscular (i.m.) P from days 2 to 14 after TVA. Blood tests were performed on days 0, 5, 8, and 12 after TVA. Setting: The in vitro fertilization program of a tertiary care institution was the study setting. Main Outcome Measures: The main outcome measures were (1) pregnancy and implantation rates; (2) serum estradiol (E), P, and hCG levels; and (3) occurrence of side effects. Results: Clinical pregnancy and implantation rates in group 1 versus group 2 were similar (36.7 vs 35.3 and 12 vs 14%, respectively). Regardless of pregnancy occurrence, on days 8 and 12 after TVA, serum E and P levels were higher in group 1 than group 2 but the resulting E/P ratios were similar. Five of 38 patients (group 1) developed moderate to severe ovarian hyperstimulation syndrome (OHSS) right after the first or second supplementary hCG injection. In these patients, the mean serum E level on the day of hCG trigger injection was about 3250 pg/ml and the number of follicles was between 9 and 17. In 6 of 39 patients (group 2) allergic reactions were observed at the P injection sites. Conclusions: Based on our data, hCG administration as a form of luteal supplementation did not translate, in comparison to P, into significant benefits for the patients. At the same time, it significantly increased the risk of ovarian hyperstimulation. We suggest that whenever, during COH cycles, serum E levels are over 2500 pg/ml and the number of follicles exceeds 10, luteal support with hCG should be excluded.
引用
收藏
页码：74 / 78
页数：5
相关论文
共 25 条
  • [1] Daya S., Efficacy of progesterone support in the luteal phase following in vitro fertilization and embryo transfer, Hum Reprod, 3, pp. 731-734, (1988)
  • [2] Kupferminc M.J., Lessing J.B., Amit A., Yovel I., David M.P., Peyser, A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer, Hum Reprod, 5, pp. 271-273, (1990)
  • [3] Smitz J., Devroey P., Braeckmans P., Camus M., Khan I., Staessen C., Van Waesberghe L., Wisanto A., Van Steirtghem A.C., Management of failed cycles in an IVF/GIFT programme with the combination of a GnRh analogue and HMG, Hum Reprod, 2, pp. 309-314, (1987)
  • [4] Smitz J., Devroey P., Camus M., Van Waesberghe L., Wisanto A., Van Steirteghem A.C., The luteal phase and early pregnancy after combined GnRh-agonist/HMG treatment for superovulation in IVF and GIFT, Hum Reprod, 3, pp. 585-580, (1988)
  • [5] Herman A., Ron-El R., Golan A., Raziel A., Soffler Y., Caspi E., Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotrophin in in-vitro fertilization stimulated with gonadotrophin-releasing hormone analog and menotrophins, Fertil Steril, 53, pp. 92-96, (1990)
  • [6] McClure N., Leya J., Radwanska E., Rawlins R., Haning R.V., Luteal phase support and severe ovarian hyperstimulation syndrome, Hum Reprod, 7, pp. 758-764, (1992)
  • [7] de Los Santos M.J., Tarin J.J., Gomez E., Remohi J., Pellicer A., Daily measurements and in-vitro effects of human chorionic gonadotrophin in the early luteal phase, Hum Reprod, 8, pp. 2047-2051, (1993)
  • [8] Ben-Nun I., Jaffe R., Fejgin M.D., Beyth Y., Therapeutic maturation of endometrium in in-vitro fertilization and embryo transfer, Fertil Steril, 57, pp. 953-962, (1992)
  • [9] Buvat J., Marcolin G., Louvet A., Herbaut J.C., Luteal support after GnRh analog for IVF: superiority of hCG over oral progesterone, Fertil Steril, 53, (1990)
  • [10] Smitz J., Devroey P., Faguer B., Bourgain C., Camus M., Van Steirteghem A.C., A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement, Hum Reprod, 7, pp. 168-175, (1992)
123